Baxter International is a healthcare company that focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.
The company was founded by David Baxter in 1931 as a manufacturer and distributor of intravenous therapy.
Just four years later in 1935 Ralph Falk bought out David Baxter and added a research and development branch to the company.
In 1939 Baxter International developed a vacuum-type collection container that extended the shelf life of blood from hours to weeks.
In 1954 the company expanded internationally for the first time with an office in Belgium.
Today Baxter International makes a variety of medicines and medical products, operating in two divisions: Medical Products and Bio Science.
Baxter International trades publicly on the New York Stock Exchange under the symbol BAX, is a member of the S&P 500, is #185 in the Fortune 500, has 61,000 employees, and had $15.76 billion in revenue in 2013.
Baxter International
Baxter International is a healthcare company that focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.
The company was founded by David Baxter in 1931 as a manufacturer and distributor of intravenous therapy.
Just four years later in 1935 Ralph Falk bought out David Baxter and added a research and development branch to the company.
History
In 1939 Baxter International developed a vacuum-type collection container that extended the shelf life of blood from hours to weeks.
In 1954 the company expanded internationally for the first time with an office in Belgium.
Today Baxter International makes a variety of medicines and medical products, operating in two divisions: Medical Products and Bio Science.
Baxter International trades publicly on the New York Stock Exchange under the symbol BAX, is a member of the S&P 500, is #185 in the Fortune 500, has 61,000 employees, and had $15.76 billion in revenue in 2013.